- Guarantee-time biasIf a group of trial participants receiving a placebo are monitored/followed up from the moment they enrol in a trial, but the treatment for another group of trial participants does not begin straight away, this time lag can cause bias in the trial. This particular type of bias is called(...)
- Haematopoeitic Stem Cell TransplantationHaematopoeitic Stem Cell Transplantation
- HSCTHaematopoeitic Stem Cell Transplantation
- Half lifeThe time required for half the amount of a medicine to be eliminated from the body.
- Hard EndpointThe endpoint of a clinical trial is a pre-defined event: for instance, the occurrence of a disease, the occurrence of a symptom, or a particular laboratory result. Once someone reaches the endpoint, they are generally excluded from further research in the trial.A hard endpoint is an endpoint(...)
- Haute Autorité de SantéFrench Health Technology Assessment body. http://www.has-sante.fr/"
- Hazard ratioA hazard ratio is a measure of how often a particular event happens in a defined period of time in one group compared to how often it happens in another group.
- HMAHeads of Medicines Agencies (HMA) http://www.hma.eu/"
- Heads of Medicines AgenciesHeads of Medicines Agencies (HMA) http://www.hma.eu/"
- Health eventA health event can be positive or negative. An example of a health event is the development of a disease, an injury, or responding to a medicine.